2016
DOI: 10.1200/jco.2013.51.6930
|View full text |Cite
|
Sign up to set email alerts
|

Downstaging of Non–Small-Cell Lung Cancer Through Identification of Reversible Drug Toxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…Nitrofurantoin is an antibacterial agent commonly used for treatment and prevention of UTI. The incidence of pulmonary toxicity due to nitrofurantoin is estimated to lie between 0.0001% and 0.001% [1] . Although rare, nitrofurantoin-induced diffuse lung toxicity is one of the most commonly reported pulmonary drug toxicities, reflecting the increased popularity of the drug [2] .…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Nitrofurantoin is an antibacterial agent commonly used for treatment and prevention of UTI. The incidence of pulmonary toxicity due to nitrofurantoin is estimated to lie between 0.0001% and 0.001% [1] . Although rare, nitrofurantoin-induced diffuse lung toxicity is one of the most commonly reported pulmonary drug toxicities, reflecting the increased popularity of the drug [2] .…”
Section: Discussionmentioning
confidence: 99%
“…Female sex, accountable for 85–95% of cases, renal impairment and older age are associated with higher risk of this toxicity [3,4] . This phenomenon is not dose-related and can have an acute onset (approximately 90% of cases) or a chronic presentation [1,3] . Chronic pulmonary toxicity is seen primarily in older women who have been prescribed relatively small doses of nitrofurantoin for UTI prevention [3,4] .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations